Get in touch

Latest Updates

News, Stories & Healthcare Insights

  • Business, Innovation, News, People

Better Therapies for Patients Worldwide

At Tiefenbacher Group, our focus goes beyond developing medicines. We create value-added and innovative therapies by understanding the needs and challenges of everyday healthcare. By listening to patients and...

  • Business, Events, News, People, Uncategorized

See you at CPHI 2026!

We are excited to be joining the global pharmaceutical community at CPHI 2026, taking place from 6 to 8 October at Fiera Milano, Italy. 🌍💊 hashtag#CPHIMilan creates a valuable...

  • Business, Innovation, News, People

Better Affordability of Medicines

Better affordability of medicines starts with a smarter, more efficient supply chain. As our in-house manufactured portfolio continues to grow, we are strengthening our ability to simplify supply, leverage...

  • Business, Innovation, News

💊Active pharmaceutical ingredients (APIs) rarely make headlines. Yet, without them, there are no medicines

For more than 60 years, Tiefenbacher API + Ingredients has helped pharmaceutical companies across Europe secure reliable access to high-quality APIs.🌍 Today, our portfolio includes more than 2.000 APIs...

  • History, News

Did you know that one of Tiefenbacher’s first innovations wasn’t a medicine – but a completely new way of working?

When Alfred E. Tiefenbacher founded Tiefenbacher Group in 1963, active pharmaceutical ingredients were often traded anonymously, with price taking priority over transparency. Alfred believed there was a better way....

  • News, People

🌍 Connecting Sites, Strengthening Supply Chains: Meet Michael 👋

Meet Michael Stavrou, MCIPS, the first Supply Chain Operations Manager within our Supply Chain In-House Team who is based at Tiefenbacher’s manufacturing site in Cyprus. Michael is currently spending...

  • Business, Innovation, News, Product Launch

We are proud to announce the launch of Edoxaban in Romania, Estonia, and Latvia 💊

Edoxaban is an anticoagulant (“blood thinner”) used in adults with non-valvular atrial fibrillation to help prevent stroke and systemic embolism. It is also used to treat deep vein thrombosis...

  • Business, History, News

Some buildings tell the story of a city. Ours is one of them. 🏢 ✨

Completed in 1993, the building that houses Tiefenbacher Group was originally designed as Hamburg’s England Terminal, a ferry terminal connecting the city with Harwich in the United Kingdom. With...

  • Innovation, News, People

It’s Time to Rename “Generic Medicines” 💊

For decades, high-quality off-patent medicines have been known as “generics” – yet there is nothing generic about their impact. Containing the same active ingredient and meeting the same standards...

  • News, Sustainability

What defines sustainable healthcare? 🌱

Going beyond reducing environmental impact, it is about strengthening the systems patients rely on for the future. At Tiefenbacher Group, sustainability is embedded in how we develop, manufacture and...

  • News

The Value of Affordable Medicines

Affordable medicines are one of the most powerful tools for keeping healthcare systems sustainable. ♻️ 🌱 According to an IQVIA 2024 report, in Europe, affordable pharmaceuticals (so-called “generics”) account...

  • News

Apremilast 10mg, 20mg and 30mg tablets are now launched in Europe

We are proud to announce the launch of Apremilast 10 mg, 20 mg, and 30 mg tablets in Europe. 💊 Developed and manufactured in-house by Tiefenbacher Group, Apremilast is...

Get in touch